Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 2
1974 3
1975 2
1976 3
1977 2
1978 5
1979 3
1981 1
1982 1
1983 1
1984 4
1985 5
1986 5
1987 3
1988 3
1989 1
1990 4
1991 3
1992 3
1993 2
1994 1
1995 1
1996 2
1997 2
1998 3
1999 1
2000 2
2001 4
2002 2
2003 3
2004 4
2005 3
2006 3
2007 3
2008 2
2010 3
2011 3
2012 1
2013 3
2014 2
2016 1
2017 2
2018 4
2019 3
2020 6
2021 6
2022 3
2023 2
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria.
Röth A, Nishimura JI, Nagy Z, Gaàl-Weisinger J, Panse J, Yoon SS, Egyed M, Ichikawa S, Ito Y, Kim JS, Ninomiya H, Schrezenmeier H, Sica S, Usuki K, Sicre de Fontbrune F, Soret J, Sostelly A, Higginson J, Dieckmann A, Gentile B, Anzures-Cabrera J, Shinomiya K, Jordan G, Biedzka-Sarek M, Klughammer B, Jahreis A, Bucher C, Peffault de Latour R. Röth A, et al. Among authors: soret j. Blood. 2020 Mar 19;135(12):912-920. doi: 10.1182/blood.2019003399. Blood. 2020. PMID: 31978221 Free PMC article. Clinical Trial.
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial.
Risitano AM, Röth A, Soret J, Frieri C, de Fontbrune FS, Marano L, Alashkar F, Benajiba L, Marotta S, Rozenberg I, Milojevic J, End P, Nidamarthy PK, Junge G, Peffault de Latour R. Risitano AM, et al. Among authors: soret j. Lancet Haematol. 2021 May;8(5):e344-e354. doi: 10.1016/S2352-3026(21)00028-4. Epub 2021 Mar 23. Lancet Haematol. 2021. PMID: 33765419 Clinical Trial.
Comprehensive analysis of mesenchymal cells reveals a dysregulated TGF-β/WNT/HOXB7 axis in patients with myelofibrosis.
Ganesan S, Awan-Toor S, Guidez F, Maslah N, Rahimy R, Aoun C, Gou P, Guiguen C, Soret J, Ravdan O, Bisio V, Dulphy N, Lobry C, Schlageter MH, Souyri M, Giraudier S, Kiladjian JJ, Chomienne C, Cassinat B. Ganesan S, et al. Among authors: soret j. JCI Insight. 2024 Dec 6;9(23):e173665. doi: 10.1172/jci.insight.173665. JCI Insight. 2024. PMID: 39470742 Free PMC article.
Francisella tularensis meningitis.
Contentin L, Soret J, Zamfir O, Gontier O, Lherm T, Hamrouni M, Ouchenir A, Monchamps G, Kalfon P. Contentin L, et al. Among authors: soret j. Med Mal Infect. 2011 Oct;41(10):556-8. doi: 10.1016/j.medmal.2011.07.004. Epub 2011 Aug 9. Med Mal Infect. 2011. PMID: 21831551 No abstract available.
[Myeloproliferative syndromes].
Soret J, Kiladjian K. Soret J, et al. Rev Prat. 2021 Feb;71(2):e39-e49. Rev Prat. 2021. PMID: 34160990 French. No abstract available.
[Postpartum hemorrhagic syndrome].
Coquerel A, Soret J, Benkemoun R. Coquerel A, et al. Among authors: soret j. Anesth Analg (Paris). 1974 May-Jun;31(3):449-57. Anesth Analg (Paris). 1974. PMID: 4548325 French. No abstract available.
[Substitute bladders].
Lobel B, Guille F, Soret JY. Lobel B, et al. Among authors: soret jy. Presse Med. 1990 Jun 9;19(23):1094-9. Presse Med. 1990. PMID: 2141413 French.
myb-specific probes.
Martinerie C, Soret J, Perbal B. Martinerie C, et al. Among authors: soret j. Nucleic Acids Res. 1987 Feb 11;15(3):1329-30. doi: 10.1093/nar/15.3.1329. Nucleic Acids Res. 1987. PMID: 3029704 Free PMC article.
124 results